Predictors of Non-response or Loss of Response to Tumour Necrosis Factor Antagonist Therapies in Inflammatory Bowel Disease

Khalid Javaria Mona; Peyrin-Biroulet Laurent; Armuzzi Alessandro; Gisbert Javier P.; Nguyen Geoffrey; Bokemeyer Bernd; Lindsay James; Smyth Michael; Munsaka Melvin; Ramagopalan Sreeram

首页> 外文期刊>The American Journal of Gastroenterology >Predictors of Non-response or Loss of Response to Tumour Necrosis Factor Antagonist Therapies in Inflammatory Bowel Disease

【24h】

Predictors of Non-response or Loss of Response to Tumour Necrosis Factor Antagonist Therapies in Inflammatory Bowel Disease

机译：炎症性肠病中对肿瘤坏死因子拮抗剂治疗无反应或无反应的预测因子

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The American Journal of Gastroenterology》 |2016年第1期|共1页
作者
Khalid Javaria Mona; Peyrin-Biroulet Laurent; Armuzzi Alessandro; Gisbert Javier P.; Nguyen Geoffrey; Bokemeyer Bernd; Lindsay James; Smyth Michael; Munsaka Melvin; Ramagopalan Sreeram;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Predictors of Non-response or Loss of Response to Tumour Necrosis Factor Antagonist Therapies in Inflammatory Bowel Disease [J] . Khalid Javaria Mona, Peyrin-Biroulet Laurent, Armuzzi Alessandro, The American Journal of Gastroenterology . 2016,第Suppla1期

机译：炎症性肠病中对肿瘤坏死因子拮抗剂治疗无反应或无反应的预测因子
2. Immunomodulator use does not prevent first loss of response to anti-tumour necrosis factor alpha therapy in inflammatory bowel disease: long-term outcomes in a real-world cohort [J] . Varma Poornima, Rajadurai Anton S., Holt Darcy Q., Internal medicine journal . 2019,第6期

机译：免疫调节器使用不会阻止对炎症性肠病抗肿瘤坏死因子α治疗的第一次丧失响应：真实世界的队列中的长期结果
3. Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) [J] . Drugs and aging . 2020,第5期

机译：与患者炎症性肠疾病患者抗肿瘤坏死因子治疗的持久性与患者相比：来自炎症性肠疾病的西西里网络数据（SN-IBD）
4. Predictive factors of the course and therapeutic response in inflammatory bowel disease [C] . K.TAKEUCHI, M. LADWA, I. BJARNASON Falk Symposium . 2004

机译：炎症性肠病课程的预测因素及治疗反应
5. Biolo?ki Procesi in Napovedovanje Neodzivnosti Na Zaviralce Dejavnika Tumorske Nekroze Pri Crohnovi Bolezni z Integracijo Genomskih Podatkov =Biological processes and predicting non-response to tumor necrosis factor inhibitors in Crohn's disease by integr [D] . Jezernik, Gregor. 2021

机译：通过整合基因组数据=生物学过程和预测携带基因组疾病肿瘤疾病肿瘤坏死因子抑制剂的生物过程和预测性
6. Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis [O] . Siddharth Singh, John George, Brigid S Boland, -1

机译：肿瘤坏死因子拮抗剂的原发性无反应与炎症性肠病患者对二线生物制剂的不良反应相关：系统评价和荟萃分析
7. P282 High plasma oncostatin-M predicts non-response to tumour necrosis factor-alpha antagonists in inflammatory bowel disease [O] . A Guo, C Ross, N Chande, 2021

机译：p282高血浆oncostatatin-m预测肿瘤坏死因子-α拮抗剂在炎症性肠病中的抗反应

Predictors of Non-response or Loss of Response to Tumour Necrosis Factor Antagonist Therapies in Inflammatory Bowel Disease

著录项

相似文献

相关主题

期刊订阅